2024

  • August: Added new scope to the journal: Pharmaceutical Education

2023

  • February: Changes to Article Templates to Single-column

2022

  • February: Indexed by CABI (CAB Abstracts and Global Health database)

2021

  • August: Included in the list of Journals stating that they follow the ICMJE Recommendations
  • August: Indexed by CAS
  • June: Issued the first Special Issue on the theme of COVID-19
  • February: Changed citation styles to Vancouver Style

2020

  • June: Issued the first Special Issue on the theme of COVID-19
  • February: Present galleys in XML format
  • February: Increase the frequency of publications to four times a year
  • January: Accepted to be indexed in EMBASE by Elsevier

2019

  • October: Indexed in DOAJ and Index Copernicus International Journals Master List
  • August: Integrated with PlumX and Publons
  • August: Indexed in Dimensions and ResearchBib
  • July: Changes to Article Templates starting from Volume 2 Number 2 November 2019 which substituting article fonts from Gill Sans MT becomes Book Antiqua to accommodate several character specials. The latest template is available (here)
  • June: Obtain support from overseas reviewers from several countries such as Brunei Darussalam, Russia, India, Libya, Finland, and Ukraine
  • May: First published all articles in English in one edition from Volume 2 Issue 1 May 2019
  • April: Experience changes to the applicable template starting from Volume 2 Issue 1 May 2019 to make the appearance of the article more interesting, using the new template (here)

2018

  • November: Indexed in Crossref and ROAD
  • November: First published articles in English in one edition
  • August: Obtaining a DOI Crossref Prefix 10.33084 as a result of collaboration with Relawan Jurnal Indonesia
  • June: Indexed in Google Scholar, Indonesia OneSearch, BASE, and WorldCat
  • May: Have an online ISSN with numbers 2621-4814
  • May: Started to publish an electronic edition on the domain http://journal.umpalangkaraya.ac.id with the OJS 3.1.1.2 platform, using the first template (here)